The efficacy of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy has been established in several controlled clinical trials. [17,18,19] These trials ...

Please provide your email address to receive an email when new articles are posted on . Pregabalin targets the a2-delta auxiliary subunit of voltage-gated calcium channels. Patients with RDEB in this ...

Review of 2 pivotal phase 3 trials that evaluated the efficacy and safety of pregabalin for the management of FM. Results: FM is a chronic condition that is characterized by widespread musculoskeletal ...

AUSTIN, TX—Duloxetine, pregabalin, and duloxetine + gabapentin were found to be safe and tolerable for the treatment of diabetic peripheral neuropathic pain, according to results presented today at ...

To characterize the comorbidities, pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia (FM) newly prescribed pregabalin in clinical practice. These results ...

Health Ministry on Friday said it has notified the inclusion of the drug ‘Pregabalin’ under Schedule H1 of the Drugs Rules, ...

Pregabalin is commonly prescribed for chronic pain, neuropathies, fibromyalgia, and certain neurological conditions ...

India, May 25 -- Pregabalin has now been placed under Schedule H1 of the Drugs Rules, 1945, as authorities intensify efforts to control misuse and unauthorized sales of the painkiller, especially ...

Retrospective cohort study compared heart failure risks of two nonopioid medications using Medicare data. The more potent pregabalin was associated with more heart failure events than gabapentin.

Pegasus Laboratories, Inc. (Pegasus), under its registered trademark PRN® Pharmacal brand, today announced that the U.S. Food and Drug Administration (FDA) has granted conditional approval to Liavium® ...